ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. OrsoBio Splurges With Four Concurrent L
ScripGlaxoSmithKline plc has continued its flurry of R&D deal-making by becoming the latest major drug maker to partner with Sosei Heptares and inked a deal targeting immune disorders of the digestive s